| Literature DB >> 26608988 |
Xue Mei, Chen-Chen Hang, Shuo Wang, Chun-Sheng Li1, Ze-Xing Yu.
Abstract
BACKGROUND: Majority of the research on cardiac arrest (CA) have focused on post-CA brain injury and myocardial dysfunction, the renal dysfunction and acute kidney injury (AKI) in other critical illnesses after CA have not been well described. This study was designed to assess AKI with renal Doppler and novel AKI biomarkers in a swine model of ventricular fibrillation cardiac arrest (VFCA).Entities:
Mesh:
Substances:
Year: 2015 PMID: 26608988 PMCID: PMC4795242 DOI: 10.4103/0366-6999.169094
Source DB: PubMed Journal: Chin Med J (Engl) ISSN: 0366-6999 Impact factor: 2.628
Pathologic change for a semi-quantitative evaluation of kidney injury
| Grade | Pathologic changes under light microscope |
|---|---|
| 0 - Normal | Renal histopathology |
| 1 - Mild | Mild interstitial edema, renal tubular necrosis, slight glomerular capillaries angiectasis, and inflammatory cells infiltration |
| 2 - Moderate | Pathologic changes of renal between mild and severe |
| 3 - Severe | Severe interstitial edema, renal tubular necrosis, severe glomerular capillaries angiectasis, mesangial proliferation, and severe inflammatory cells infiltration |
Hemodynamics of HR, MAP and CO of the VFCA group and Sham group (Sham group, n = 8; VFCA group, n = 22) (mean ± SD)
| Items | HR (bpm/min) | MAP (mmHg) | CO (L/min) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sham | VFCA | Sham | VFCA | Sham | VFCA | |||||||
| Baseline | 95.0 ± 9.2 | 93.0 ± 5.4 | 0.470 | 0.499 | 92.3 ± 4.1 | 91.9 ± 5.0 | 0.914 | 0.843 | 2.80 ± 0.08 | 2.84 ± 0.09 | 1.435 | 0.242 |
| ROSC 2 h | 90.1 ± 6.2 | 143.7 ± 10.0* | 194.983 | <0.001 | 92.0 ± 4.8 | 102.3 ± 10.0* | 606.229 | 0.010 | 2.79 ± 0.10 | 2.14 ± 0.08* | 323.575 | <0.001 |
| ROSC 4 h | 90.4 ± 6.2 | 123.2 ± 5.9* | 171.565 | <0.001 | 91.9 ± 5.1 | 84.9 ± 5.8* | 282.004 | 0.006 | 2.84 ± 0.10 | 2.06 ± 0.08* | 447.207 | <0.001 |
| ROSC 6 h | 91.9 ± 6.3 | 114.5 ± 9.3* | 29.398 | <0.001 | 91.3 ± 3.0 | 86.1 ± 4.9† | 151.557 | 0.011 | 2.84 ± 0.08 | 2.15 ± 0.06* | 606.029 | <0.001 |
| ROSC 12 h | 92.4 ± 5.4 | 111.6 ± 8.3* | 36.349 | <0.001 | 92.9 ± 3.9 | 90.4 ± 5.2 | 36.432 | 0.227 | 2.83 ± 0.08 | 2.18 ± 0.05* | 599.364 | <0.001 |
| ROSC 24 h | 94.3 ± 5.5 | 103.0 ± 9.6† | 5.781 | 0.024 | 91.1 ± 3.6 | 93.6 ± 5.4 | 33.604 | 0.255 | 2.82 ± 0.11 | 2.23 ± 0.06* | 337.949 | <0.001 |
*P < 0.01, †P < 0.05 versus baseline, which were detected by the repeated measure ANOVA. P value in the table: Sham group versus VFCA group, which was detected by the multivariate ANOVA. SD: Standard deviation; ROSC: Return of spontaneous circulation; HR: Heart rate; MAP: Mean arterial pressure; CO: Cardiac output; VFCA: Ventricular fibrillation cardiac arrest.
AKI biomarkers and Color Doppler parameters of the VFCA group and Sham group (Sham group, n = 8; VFCA group, n = 22) (mean ± SD)
| Items | sCr (umol/L) | sNGAL (ng/ml) | uNGAL (ng/ml) | sCysC (ng/ml) | uCysC (ng/ml) | PI | RI | cRI | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sham | VFCA | Sham | VFCA | Sham | VFCA | Sham | VFCA | Sham | VFCA | Sham | VFCA | Sham | VFCA | Sham | VFCA | |||||||||||||||||
| Baseline | 63.2 ± 1.3 | 62.9 ± 3.3 | 0.104 | 0.749 | 2.21 ± 0.10 | 2.23 ± 0.08 | 0.387 | 0.540 | 0.62 ± 0.04 | 0.63 ± 0.04 | 0.203 | 0.656 | 513.5 ± 3.6 | 515.4 ± 9.8 | 0.296 | 0.591 | 212.6 ± 4.4 | 214.0 ± 5.6 | 0.420 | 0.523 | 0.82 ± 0.03 | 0.82 ± 0.03 | 0.021 | 0.887 | 0.44 ± 0.03 | 0.43 ± 0.03 | 0.030 | 0.846 | 0.48 ± 0.03 | 0.47 ± 0.03 | 0.286 | 0.597 |
| ROSC 6 h | 62.3 ± 2.5 | 63.1 ± 2.8 | 0.530 | 0.473 | 2.22 ± 0.06 | 5.34 ± 1.68* | 27.060 | <0.001 | 0.62 ± 0.03 | 3.33 ± 1.52* | 25.076 | <0.001 | 511.2 ± 4.4 | 777.5 ± 169.7* | 19.251 | <0.001 | 215.2 ± 8.9 | 359.8 ± 86.8* | 25.076 | <0.001 | 0.82 ± 0.03 | 0.73 ± 0.03* | 67.969 | <0.001 | 0.44 ± 0.03 | 0.53 ± 0.04* | 33.666 | <0.001 | 0.48 ± 0.02 | 0.62 ± 0.04* | 83.167 | <0.001 |
| ROSC 12 h | 63.5 ± 3.0 | 65.8 ± 2.5 | 4.578 | 0.042 | 2.23 ± 0.11 | 4.05 ± 0.95* | 28.591 | <0.001 | 0.62 ± 0.03 | 2.29 ± 0.91* | 26.096 | <0.001 | 514.9 ± 6.8 | 864.2 ± 202.3* | 23.298 | <0.001 | 215.1 ± 7.4 | 426.1 ± 125.0* | 22.264 | <0.001 | 0.82 ± 0.03 | 0.68 ± 0.05* | 59.336 | <0.001 | 0.43 ± 0.02 | 0.54 ± 0.06* | 24.425 | <0.001 | 0.46 ± 0.03 | 0.62 ± 0.07* | 42.244 | <0.001 |
| ROSC 24 h | 63.2 ± 3.4 | 91.8 ± 20.5* | 15.036 | 0.001 | 2.20 ± 1.12 | 3.16 ± 0.69* | 15.072 | 0.001 | 0.62 ± 0.03 | 1.41 ± 0.31* | 51.03 | <0.001 | 519.7 ± 3.5 | 1304.4 ± 407.8* | 28.949 | <0.001 | 213.6 ± 3.1 | 475.5 ± 115.7* | 40.058 | <0.001 | 0.82 ± 0.03 | 0.68 ± 0.04* | 70.000 | <0.001 | 0.44 ± 0.03 | 0.59 ± 0.06* | 51.136 | <0.001 | 0.47 ± 0.04 | 0.64 ± 0.06* | 53.771 | <0.001 |
*P<0.01 versus baseline, which were detected by the repeated measure ANOVA. P value in the tabel: Sham group versus VFCA group, which was detected by an independent sample t-test or the multivariate ANOVA. SD: Standard deviation; AKI: Acute kidney injury; ROSC: Return of spontaneous circulation; sCr: Serum creatinine; sNGAL: Serum neutrophil gelatinase-associated lipocalin; uNGAL: Urine neutrophil gelatinase-associated lipocalin; sCysC: Serum cystatin C; uCysC: Urine cystatin C; PI: Pulsatility index; RI: Resistive index; cRI: Corrected resistive index; VFCA: Ventricular fibrillation cardiac arrest.
Figure 1Renal Color Doppler flow image. (a) Color Doppler flow image at baseline. (b) Color Doppler flow image at ROSC 6 h. (c) Color Doppler flow image at ROSC 12 h. (d) Color Doppler flow image at ROSC 24 h. ROSC: Restoration of spontaneous circulation; PSV: Peak systolic velocity; EDV: End diastolic velocity; MDV: Minimum diastolic velocity; RI: Resistive index; PI: Pulsatility index.
Figure 2Renal ultra-microstructure and TUNEL staining images of renal apoptotic cells 24 h after ROSC of the VFCA (b-d, f), Sham (a, e) group (a-d, H and E, original magnification ×400; e, f, TUNEL, original magnification ×400). (a) Normal, Grade 0; (b) Grade 1, Mild injury: ① Interstitial edema. (c) Grade 2, Moderate injury: ② Mesangial inflammatory cells infiltration. ③ Renal tubular necrosis. (d) Grade 3, Severe injury: ④ Glomerular capillaries angiectasis. TUNEL: Terminal deoxynucleotidyl transferase-mediated 2-deoxyuridine 5-triphosphate nick end labeling; H and E: Hematoxylin and erosin; VFCA: Ventricular fibrillation cardiac arrest.
Correlations of sNGAL, sCysC, CO and grade of renal injury
| Index 1 | Index 2 | ||
|---|---|---|---|
| sNGAL | uNGAL | 0.946 | <0.001 |
| sCysC | uCysC | 0.891 | <0.001 |
| CO | RI | −0.653 | <0.001 |
| CO | cRI | −0.723 | <0.001 |
| Grade of renal injury | ROSC time | 0.701 | <0.001 |
| Grade of renal injury | sNGAL | 0.459 | <0.001 |
| Grade of renal injury | sCysC | 0.809 | <0.001 |
| Grade of renal injury | RI | 0.402 | 0.034 |
| Grade of renal injury | cRI | 0.439 | 0.019 |
NGAL: Neutrophil gelatinase-associated lipocalin; sNGAL: Serum neutrophil gelatinase-associated lipocalin; uNGAL: Urine neutrophil gelatinase-associated lipocalin; CysC: cystatin C; sCysC: Serum cystatin C; uCysC: Urine cystatin C; CO: Cardiac output; ROSC: Return of spontaneous circulation; RI: Resistive index; cRI: Corrected resistive index.